BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20004201)

  • 1. Phosphatidylinositol 3-kinase gamma inhibition ameliorates inflammation and tumor growth in a model of colitis-associated cancer.
    González-García A; Sánchez-Ruiz J; Flores JM; Carrera AC
    Gastroenterology; 2010 Apr; 138(4):1374-83. PubMed ID: 20004201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.
    Peng XD; Wu XH; Chen LJ; Wang ZL; Hu XH; Song LF; He CM; Luo YF; Chen ZZ; Jin K; Lin HG; Li XL; Wang YS; Wei YQ
    J Pharmacol Exp Ther; 2010 Jan; 332(1):46-56. PubMed ID: 19828878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.
    van Dop WA; Marengo S; te Velde AA; Ciraolo E; Franco I; ten Kate FJ; Boeckxstaens GE; Hardwick JC; Hommes DW; Hirsch E; van den Brink GR
    Immunol Lett; 2010 Jun; 131(1):33-9. PubMed ID: 20347874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
    Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
    Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
    Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
    J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
    Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
    Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
    Aviello G; Corr SC; Johnston DG; O'Neill LA; Fallon PG
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G769-78. PubMed ID: 24603458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
    Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
    Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of natural killer T cells in the mouse colitis-associated colon cancer model.
    Yoshioka K; Ueno Y; Tanaka S; Nagai K; Onitake T; Hanaoka R; Watanabe H; Chayama K
    Scand J Immunol; 2012 Jan; 75(1):16-26. PubMed ID: 21815907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer.
    Tang RJ; Shen SN; Zhao XY; Nie YZ; Xu YJ; Ren J; Lv MM; Hou YY; Wang TT
    Stem Cell Res Ther; 2015 Apr; 6(1):71. PubMed ID: 25889203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment.
    Habtezion A; Toivola DM; Butcher EC; Omary MB
    J Cell Sci; 2005 May; 118(Pt 9):1971-80. PubMed ID: 15840656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.